SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys multi-year agreement to supply engines, license propulsion technology, and provide engineering support for AST SpaceMobiles planned rocket is driving attention and a sharp rally. Traders view the deal as validation of Fireflys engine business and a boost to its backlog, while some question the payment mix, potential dilution, and execution risks.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklos sharp rebound is being tied to its Q3 update and an agreement reserving future reactor-component manufacturing capacity; bulls also point to its cash position and expected power demand from AI data centers. Bears counter that the company remains pre-commercial, with long development timelines, dilution concerns, insider selling, and a valuation they consider difficult to justify.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is drawing attention amid volatile gold trading: stronger-than-expected U.S. jobs data and a firmer dollar have raised Fed-hike concerns and pressured bullion, following an election-linked rally as the dollar and yields weakened. Traders are divided over whether gold is regaining safe-haven appeal or remains vulnerable to further selling.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

A sharp rebound after a prolonged selloff has traders debating whether the move signals a recovery or is a low-volume dead-cat bounce; some speculate about short covering or an options-driven squeeze, while others expect renewed selling. The discussion also centers on whether Ondass drone-defense contracts and acquisition-led growth will show through in its earnings results.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the following business segments: Cannabis and Plant Propagation. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

Auroras agreed acquisition by Organigram is driving attention, with traders debating whether Curaleaf will make a higher counterbid and whether the deal undervalues ACB shareholders. Some welcome the buyout catalyst, while others object to the terms and potential dilution; the transaction remains subject to approvals.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs attention centers on anticipated topline results from the Phase 3 REGAL trial of GPS, following the reported 80th trial event; traders also point to upcoming SLS009 data at ASH. Bulls expect positive results and speculate about a buyout, while skeptics cite the stocks weakness and uncertainty around the readoutno result or acquisition is confirmed.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs strong quarterly results and raised full-year revenue outlook are driving attention, with traders also pointing to a growing backlog and quantum-sector momentum. Bulls view the report as evidence of commercial progress, while skeptics cite cash burn, acquisition-driven revenue and dilution risks.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin Trust ETF

Bitcoins pullback below key support and reported withdrawals from spot Bitcoin ETFs are driving attention to IBIT. Traders are divided between calling the weakness a dip-buying opportunity and warning that further declines may follow.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris strong Q3 results and raised revenue outlook are driving attention, with traders highlighting rapid Recorlev growth and a higher long-term revenue projection. The reaction is broadly bullish, while buyout and bidding-war talk remains speculation rather than a confirmed catalyst.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigels Q3 results triggered a sharp selloff, with traders criticizing the earnings performance despite revenue growth and updated guidance. The debate centers on whether VEPPANUs early launch traction can drive growth, while investors weigh that opportunity against near-term execution concerns and the upcoming R289 data.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
